Ambulatoriya Za Individualna Praktika Za Spetsializirana Meditsinska Pomosht (AIPSMP) Po Kardiologiya D-R Trendafil Tonkov Ltd.

Verified siteinfo

Bulgaria Mihail Takev 21, 4000 Plovdiv, Bulgaria

1 trial recruiting
Heart failure with preserved ejection fraction · Obesity · Arteriosclerosis
Adult patients

About Specializations

Ambulatoriya Za Individualna Praktika Za Spetsializirana Meditsinska Pomosht (AIPSMP) Po Kardiologiya D-R Trendafil Tonkov Ltd. in Plovdiv, Bulgaria specialises in clinical trials of conditions such as Heart failure with preserved ejection fraction, Obesity, Arteriosclerosis, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The Ambulatoriya Za Individualna Praktika Za Spetsializirana Meditsinska Pomosht (AIPSMP) in Plovdiv concentrates on cardiovascular diseases, seeking better outcomes for patients with heart‑failure syndromes and atherosclerotic risk.

Atherosclerotic cardiovascular disease
Heart failure with preserved ejection fraction (HFpEF)
Heart failure with mildly reduced ejection fraction (HFmrEF)
Overweight and obesity as cardiovascular risk factors
Use of SGLT2 inhibitors as background therapy

Current trials assess novel therapies such as elecoglipron and zenagamtide to lower cardiovascular death, urgent heart‑failure visits, and major adverse cardiovascular events, building on standard care practices.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Mihail Takev 214000 PlovdivBulgaria

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 4
Partner status: Verified site

More sites in Plovdiv Bulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

2 clinical trials

Heart failure with preserved ejection fraction

Recruiting

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug